Phase 2 Small Cell Carcinoma of Lung Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI Treatment
Small Cell Carcinoma of Lung
Se-Hoon Lee50 enrolled1 locationNCT06830694
Recruiting
Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
Non-Small Cell Carcinoma of Lung, TNM Stage 4
Fox Chase Cancer Center117 enrolled1 locationNCT03786692